Boehringer Ingelheim

Boehringer Ingelheim Driving healthcare innovation for people and animals.
Welcome to our Facebook channel. g.

We are a German research-driven pharmaceutical company and it’s our goal to improve the lives of humans and animals worldwide. Country-specific content may have been issued in the countries where we do business. Follow us for news about healthcare topics, our research & development and company updates. This is a place where you can share your thoughts, and connect with other people. We are looking forward to exchanging ideas and engaging in conversations! We want to ensure that this is a safe and informative environment and respectfully request that you follow our Community Guidelines:

• Be nice to each other, even if you disagree

• Be constructive and inspire further conversations

• Please do not provide diagnoses or treatment advice

• We don’t tolerate discriminatory or derogatory comments, hate speech, especially humiliation of people or groups of people

• We don’t tolerate threats and requests for violence against anyone or anything

• We don’t tolerate po*******hy, profanity, and other content that puts young people at risk

• Please don’t infringe on the applicable legislation (e. on data protection), copyrights or trademarks

• The comment function should not be misused as advertising space or for other off-topic subjects

• We don’t tolerate the promotion of illegal activities


You acknowledge that you, not Boehringer Ingelheim, are responsible for the contents of your submission. We reserve ourselves the right to delete or hide any content on our social media pages that violate the Community Guidelines.

Extrapulmonary neuroendocrine carcinoma (epNEC) is a rare and aggressive subgroup of neuroendocrine carcinomas (NECs) oc...
21/11/2025

Extrapulmonary neuroendocrine carcinoma (epNEC) is a rare and aggressive subgroup of neuroendocrine carcinomas (NECs) occurring in multiple organs outside of the lung. With limited treatment options and a challenging prognosis, the median survival is just 7.7 months.

Our dedicated research efforts aim to transform this narrative and improve patient outcomes.

Discover more about ongoing initiatives and advancements in understanding epNEC: https://go.boehringer.com/rF1OC

19/11/2025

Biomarker testing is a key part of cancer care and helps to improve the cancer care path to each patient's unique needs. As more people undergo these important tests, it's crucial that they understand what the results mean for their healthcare options.

Knowing your biomarker status can guide decisions and empower you to play an active role in your cancer care journey.

Danielle Hicks, Chief Patient Officer at GO2 for Lung Cancer shared valuable insights that highlight the importance of raising awareness and understanding, so that everyone can make informed choices about their health.

17/11/2025

Small changes, big impact!

From managing blood pressure to staying active, everyday habits play an important role in protecting your heart and interconnected organs, like your kidneys.

Discover how simple tips can support your every day.

13/11/2025

Does your ferocious feline turn into a scaredy cat at the vet? Cats get stressed in unfamiliar situations so getting your cat used to transport can go a long way. Veterinarian and cat expert Dr. Teresa Baur-Rehme (Ludwig-Maximilians-Universität München) shares tips.

13/11/2025

Paper leaflets are hard to read, harder to fold back, and often end up in the trash without a second glance. But what if there was a smarter way?

💡Say hello to electronic product information (ePI) - a digital solution that could finally put an end to the paper chaos.

➡️ Discover how ePI is transforming the leaflet experience: go.boehringer.com/jT9Ay

Extrapulmonary neuroendocrine carcinoma (epNEC) is an aggressive and often misdiagnosed type of cancer, occurring in mul...
11/11/2025

Extrapulmonary neuroendocrine carcinoma (epNEC) is an aggressive and often misdiagnosed type of cancer, occurring in multiple organs outside of the lung, including the breast, urogenital system, skin, head and neck.

By collaborating with dedicated patient organizations like Minkahz NETs Mission, we can advocate for greater awareness and resources for those affected – driving meaningful change.

Learn more about epNEC and the ongoing efforts to improve outcomes for patients: https://go.boehringer.com/YPy9_

The impact biomarkers have on cancer care is profound.     In non-small cell lung cancer (NSCLC), one of them is known a...
09/11/2025

The impact biomarkers have on cancer care is profound.

In non-small cell lung cancer (NSCLC), one of them is known as HER2 mutations, and it can greatly affect how the disease progresses and behaves. Identifying these mutations is crucial for creating personalized cancer care plans.

Learn more about the role of biomarker testing: https://go.boehringer.com/SNNWs

Biomarkers – like gene mutations, proteins, or other substances - are crucial in managing non-small cell lung cancer (NS...
05/11/2025

Biomarkers – like gene mutations, proteins, or other substances - are crucial in managing non-small cell lung cancer (NSCLC). For instance, HER2 mutations, present in some NSCLC cases, can lead to rapid cancer growth, influencing care decisions and outcomes.
By understanding biomarkers, oncologists can tailor cancer care to suit individual patients' needs.

Explore how these genetic insights are transforming lung cancer care: https://go.boehringer.com/IktE

05/11/2025

Did you know that (CKD) is closely linked to cardiovascular disease (CVD)?

CKD often has no symptoms in its early stages, but if left undetected it can affect other important organs – like your heart.

If you have heart disease, you could be at risk. Early screening helps protect both your kidneys and your heart.

Know your risks. Learn more here: https://go.boehringer.com/URG76

03/11/2025

In lung cancer, the presence of specific biomarkers can be crucial for guiding informed healthcare decisions.

In some non-small cell lung cancer (NSCLC) cases, mutations in the HER2 gene can cause cells to grow uncontrollably, leading to cancer.

Identifying these biomarkers is crucial for determining the most effective cancer care path and improving outcomes.

Explore how biomarker testing in lung cancer can make a real difference: https://go.boehringer.com/2USzw

30/10/2025

What does a chicken farm in Argentina have to do with your health? Everything.

Through our collaboration with the Andar Farm, we're educating the next generation of vets and farmers on sustainable and safe farming practises to limit the spread of disease.

Everything is connected, and protecting animal health means we're protecting human health too.

Find out more here: https://go.boehringer.com/k1hA8

Adresse

Boehringer Ingelheim GmbH, Binger Straße 173
Ingelheim Am Rhein
55216

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Boehringer Ingelheim erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an Boehringer Ingelheim senden:

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram